Connect Biopharma Holdings Limited
CNTB · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -97.5% | -92.1% | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 90.4% | 98% | – |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -27,610.4% | -1,196.1% | 34% | – |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -26,872.9% | -1,214.2% | 31.7% | – |
| EPS Diluted | -0.23 | -0.42 | 0.14 | -0.52 |
| % Growth | 45.2% | -400% | 126.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |